COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Guidance for cancer researchers:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Immunology Webinar Series

UPDATE--The online Immunology Workshop originally planned for June 8-12 and 15-18, 2020 has been reschdeuled to May 18-22, 25-28, 2020. The meeting time (11am-1pm EDT) and workshop agenda remain unchanged.  

FREE Online Immunology Workshop

Molecular and Cellular Immunology: From Basics to Applications in Preclinical Development of Nanotechnology-Formulated Drugs

May 18-22, 25-28, 2020—11am-1pm EST


Thank you to those of you who attended the December 2019 iteration of this workshop. If you have any comments, questions, or feedback on the workshop or its content, please feel free to send them to us at

The next iteration of the workshop will take place May 18-22 and 25-28, 2020. It spans nine (9) days and includes one 2-hour lecture per day. Registration is FREE but participants must sign-up by sending an e-mail to by May 14, 2020.


The June on-line workshop includes lectures covering fundamental aspects of the immune system structure and function at both molecular and cellular levels, principles of immunotoxicology, regulatory requirements for assessing the immunotoxicity of new pharmaceutical products, methodology relevant to the immunotoxicity assessment of nanomaterials and case-studies focusing on the critical structure-activity relationship between nanoparticles and the immune system.

The first five lectures cover materials described in “Cellular and Molecular Immunology,” 9th edition, Abbas, A., Lichtman A., and Pillai, S. The purpose of these lectures is to create a strong foundation of basic immunology concepts. The Part I lectures are intended for students and researchers without prior training in immunology.

Lectures 6-9 are intended for attendees of Part I and researchers with a background in immunology who want to learn applied immunotoxicology aspects of preclinical nanoparticle characterization.

· Lecture 6 covers the basic principles of immunotoxicology and reviews information summarized in FDA guidance for industry documents.

· Lectures 7 and 8 will review immunotoxicology of engineered nanomaterials and the aspects of preclinical characterization.

· Lecture 9 will focus on practical applications of the current knowledge regarding nanoparticle immunotoxicity to translate nanomaterials from bench-to-bedside.


Download the brochure here, and please share with interested colleagues.